MEMORANDUM AND ORDER ON PLAINTIFF’S MOTION FOR LEAVE TO FILE A SECOND AMENDED COMPLAINT (# 30).
I. Introduction
On September 9, 2016, plaintiff Amy Drachman filed the operative first amended complaint (#20) against her former employer Boston Scientific Corporation (BSC) and several of its executive employees alleging violations of the Family Medical Leave Act, the Massachusetts Wage Act, the Americans with Disabilities Act, as well as common law claims for breach of contract and the covenant of good faith and fair dealing. Defendants moved to dismiss portions of the first amended com
Presently before the court is Drach-man’s motion for leave to file a second amended complaint (##30, 31).
II. The Facts.
General familiarity with the facts of this case is presumed.
BSC is a medical device manufacturer and Drachman’s former employer. (# 35-1 ¶¶ 5, 7.) Plaintiff began working for BSC on September 1, 2010 as BSC’s Director of Employment Policy and Compliance. Id. ¶¶ 5,11. Drachman has a medical condition that, in 2013, resulted in her taking a leave of absence from work and limited her to working in a part-time capacity after that. Id. ¶¶ 12-21.-Drachman alleges that BSC failed to make appropriate accommodations for her and ultimately terminated her because of her disability. See generally id,
III. Standard of Review.
Rule 15, Fed, R. Civ. P., provides in relevant part that “[tjhe court should freely give leave [to amend] when justice so requires.” The inquiry here is whether Drachman’s proposed amendments would be futile.
If leave to amend is sought before discovery is complete and neither party has moved for summary judgment, the accuracy of the ‘futility’ label is gauged by reference to the liberal criteria of Federal Rule of Civil Procedure 12(b)(6). See Glassman v. Computervision Corp.,90 F.3d 617 , 623 (1st Cir. 1996). In this situation, amendment is not deemed futile as long as the proposed amended complaint sets forth a general scenario which, if proven, would entitle the plaintiff to relief against the defendant on some cognizable theory.
Hatch,
Applying the Rule 12(b)(6) standard, the court must “ ‘accept as true all well-pleaded facts set forth in the [proposed] complaint and draw all reasonable inferences therefrom in the pleader’s favor.’ ” Haley v. City of Boston,
In order to pass muster under Rule 12(b)(6), Drachman must provide “enough facts to state a claim to relief that is plausible on its face.” See Bell Atl. Corp. v. Twombly,
“A claim has facial plausibility when the plaintiff pleads factual content that allows the court to draw the reasonable inference that the defendant is liable for the misconduct alleged.” Ashcroft v. Iqbal,
IV. Discussion.
The Rehabilitation Act states that:
No otherwise qualified individual with a disability in the United States ... shall, solely by reason of her or his disability, be excluded from the participation in, be denied the benefits of, or be subjected to discrimination under any program or activity receiving Federal financial assistance. ...
29 U.S.C. § 794(a). Programs or activities as they relate to corporations (such as BSC) are defined to include instances in which “assistance is extended to such corporation ... as a whole” or if the corporation “is principally engaged in the business of providing education, health care, housing, social services, or parks and recreation.” Id. at (b)(3)(A)(i-ii).
Thus, to prevail on. her § 504 claim,[ 5 ] [Drachman] must prove four elements. She must show (1) that she is disabled; (2) that she sought services from a federally funded entity; (3) that she was ‘otherwise qualified’ to receive those services; and (4) that she was denied those services ‘solely by reason of her ... disability.’
Lesley v. Hee Man Chie,
A. Receipt of Funds as a Whole — ' 29 U.S.C. § 794(b)(3)(A)(i).
As explained by the relevant 1987 Senate report, under the Rehabilitation Act “[f]ederal financial assistance extended to a corporation or other entity ‘as a whole’ refers to situations where the corporation receives general assistance that is not designated for a particular purpose.” S. REP. No. 100-64 at 17 (1987). In her revised proposed second amended complaint, Drachman alleges that “Defendant Boston Scientific ... received Federal financial assistance of $174,150 in the form of Federal grant funding in Fiscal Year 2013 while it employed Plaintiff.” (# 35-1 ¶ 102 subpart J.) In response, defendants argue that Drachman fails to allege the nature of the grant or for what purpose it was earmarked.
B. Principally Engaged in the Business of Providing Health Care — 29 U.S.C. § 794(b)(3)(A)(ii).
Drachman’s remaining proposed amendments — concerning BSC’s alleged receipt of federal funding in connection with its provision of health care — must fail. The stumbling block for plaintiff is her inability to. substantiate .adequately the contention that BSC is principally engaged in the business of providing health care.-Drachman’s sole allegation in support of her argument that BSC is a health care provider is that .BSC’s mission statement, as posted on its website, states that “Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world.” (# 31 at 6 (quoting ¶ 101 of the proposed second amended complaint).)
While it is true that “[t]he statute does not define further what it means to be ‘principally engaged’ in one of the delineated businesses, or what any of the specific businesses, e.g., [‘health care,’] entails[,]” Doe v. Salvation Army in U.S.,
V. Conclusion.
Plaintiffs Motion for Leave to File a Second Amended Complaint (# 30) is ALLOWED in part and DENIED in part.
Notes
. In addition to her motion to amend and memorandum in support, plaintiff filed a second motion containing supplemental evidence in support of her motion to amend along with a revised proposed second amended complaint. (# 35.) To the extent Drachman’s additional submission was intended to be a motion, it was denied. (#36.) That said, the court will consider the supplemental information and revised proposed second amended complaint as part of its review of Drachman’s initial motion to amend.
. While the additional claim is alleged solely against BSC, all defendants jointly opposed plaintiff’s motion for leave to amend.' See (## 32, 40.) For the sake of consistency and in accordance with their memoranda, the court will refer to the opposing party as "defendants.”
. A complete recitation of the underlying facts . of.this case can be found in this court's earlier Report and Recommendation. (# 28 at 2-7.)
. To'the extent defendants advance the argument that plaintiff’s motion should be denied because of undue delay or prejudice to them, the court is unpersuaded, Drachman posits that her claim is based in part on recently discovered information, see (# 35 ¶ 9), and the posture of the case is such that it remains in its infancy,, i.e., a scheduling conference has not been held. Thus, any need to expand the scope of discovery to include the additional claim' would have a minimal effect, given that the parameters of discovery, have yet to be defined.
. Section 504 of the Rehabilitation Act is now codified as 29 U.S.C. § 794.
. Counsel for defendants also notes that "the undersigned has been unable to verify that BSC received any such grant.” (#.40 at 5.) This is irrelevant in the context of a Rule 12(b)(6) analysis.
. The revised proposed second amended complaint states that "Defendant Boston Scientific Corporation is a global Fortune 500 medical device [c]ompany. ..,"(# 35-1 ¶ 7.)
. To the extent Drachman advances a claim under § 503 of the Rehabilitation Act, 29 U.S.C. § 793, -her claim is denied. No private right of action exists under § 503 of the Rehabilitation Act. See Healy v. Bergman, 609 F.Supp. 1448, 1451 n. 3, 1452-1453 (D. Mass. 1985) (collecting cases).
